Peripheral infiltration of remdesivir in 3 patients with COVID-19: Case series and discussion

Peripheral infiltration of remdesivir in 3 patients with COVID-19: Case series and discussion

Purpose: The coronavirus disease 2019 (COVID-19) pandemic resulted in accelerated market access to remdesivir worldwide. Therefore, data about complications experienced during use of the drug are limited. This is the first published case series (1 case report exists) to describe remdesivir infiltrat...

Full description

Bibliographic Details
Main Authors: Bet, P.M (Author), Den Brok, M.W.J (Author), Hekking, P.-P.W (Author), Jacobs, C.J (Author), Korevaar, D.A (Author), Leeuwerik, A.F (Author), Van Merendonk, L.N (Author)
Format: Article
Language:English
Published: Oxford University Press 2021
Subjects:
Adenosine Monophosphate
adenosine phosphate
aged
Aged
Aged, 80 and over
alanine
Alanine
Antiviral Agents
antivirus agent
Article
case report
case series
clinical article
computer assisted tomography
coronavirus disease 2019
coughing
COVID-19
dexamethasone
diarrhea
drug therapy
drug withdrawal
dyspnea
fatigue
female
Female
fever
ground glass opacity
hematoma
human
Humans
hyaluronidase
infiltration
injection site extravasation
interstitial pneumonia
loading drug dose
lung consolidation
male
Male
nasopharyngeal swab
oxygen therapy
peripheral infiltration
remdesivir
reverse transcription polymerase chain reaction
SARS-CoV-2
sodium chloride
swelling
very elderly
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items